Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
J Biochem ; 114(6): 919-25, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8138552

ABSTRACT

It has been suggested that the two acidic regions around residue 70 and residue 170 in yeast cytochrome c1, a subunit of ubiquinol-cytochrome c reductase (complex III), interact with cytochrome c in the electron transfer reaction and that the QCR6 protein, the acidic subunit of yeast complex III, enhances this interaction. In order to determine the roles of the acidic regions of cytochrome c1 more precisely, we introduced several mutations in the two acidic regions and examined their effects on the ability of modified cytochrome c1 to complement the respiration deficiency of yeast cells lacking only cytochrome c1 or both cytochrome c1 and the QCR6 protein. The mutant cytochrome c1 with the deletion of the first acidic region (delta 68-80) was still functional in the cytochrome c1-deficient strain. Mutant cytochrome c1 with the deletion of the second acidic region (delta 168-179) caused a decrease in the complementing ability, but this is probably due to failure in its proteolytic maturation and/or correct assembly into complex III. Mutant cytochrome c1 with altered charge distribution in the acidic regions (Asp170Asp171-->Asn170Asn171 or Asp170Asp171-->Asn170Lys171) made the cytochrome c1-deficient cells respiration-competent. On the other hand, mutant cytochrome c1 with the deletion of the first acidic region (delta 68-80) or altered charge distribution in the second region (Asp170Asp171-->Asn170Lys171) did not restore the respiration deficiency of the cells lacking not only cytochrome c1 but also the QCR6 protein.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Cytochromes c1/genetics , Electron Transport Complex III/genetics , Saccharomyces cerevisiae/enzymology , Amino Acid Sequence , Amino Acids/genetics , Blotting, Western , Cytochromes c1/chemistry , Electron Transport , Electron Transport Complex III/chemistry , Gene Deletion , Hydrogen-Ion Concentration , Mitochondria/chemistry , Molecular Sequence Data , Saccharomyces cerevisiae/genetics , Solubility , Transformation, Genetic
2.
Antimicrob Agents Chemother ; 37(4): 839-45, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8388200

ABSTRACT

The mechanism of action of quinolones was investigated by use of various DNA gyrases reconstituted from wild-type and mutant GyrA and GyrB proteins of Escherichia coli. The quinolone sensitivities of the DNA supercoiling activity of the gyrases were generally parallel to the quinolone susceptibilities of strains having the corresponding enzymes and depended on gyrase subunits but not on substrate DNA. [3H]Enoxacin did not bind to gyrase alone or DNA alone but bound to gyrase-DNA complexes when measured by a gel filtration method. There appeared to be two enoxacin binding phases, at low and high enoxacin concentrations, for the wild-type gyrase-DNA and type 2 GyrB (Lys-447 to Glu) mutant gyrase-DNA complexes but only one enoxacin binding phase at the concentrations used for the GyrA (Ser-83 to Leu) mutant gyrase-DNA and type 1 GyrB (Asp-426 to Asn) mutant gyrase-DNA complexes. New enoxacin binding sites appeared in the presence of enoxacin, and the enoxacin binding affinities for the sites, especially at low enoxacin concentrations, near the MICs for the strains having the corresponding gyrases, correlated well with the enoxacin sensitivities of the gyrases and the MICs. From the results obtained, we propose a quinolone pocket model as the mechanism of action of quinolones, in which quinolones exert their action through binding to a gyrase-DNA complex and the quinolone binding affinities for the complex are determined by both GyrA and GyrB subunits in concert.


Subject(s)
Anti-Infective Agents/pharmacology , Escherichia coli/enzymology , Topoisomerase II Inhibitors , Bacterial Proteins/biosynthesis , DNA Gyrase , DNA Topoisomerases, Type II/biosynthesis , DNA, Bacterial/isolation & purification , DNA, Bacterial/metabolism , DNA, Superhelical/biosynthesis , Electrophoresis, Polyacrylamide Gel , Enoxacin/metabolism , Escherichia coli/drug effects , Escherichia coli/genetics , Indicators and Reagents , Mutation , Plasmids , Transformation, Genetic/drug effects
3.
Antimicrob Agents Chemother ; 35(8): 1647-50, 1991 Aug.
Article in English | MEDLINE | ID: mdl-1656869

ABSTRACT

Thirteen spontaneous quinolone-resistant gyrB mutants of Escherichia coli KL16, including two that were examined previously, were divided into two types according to their quinolone resistance patterns. Type 1 mutants were resistant to all the quinolones tested, while type 2 mutants were resistant to acidic quinolones and were hypersusceptible to amphoteric quinolones. Nucleotide sequence analysis disclosed that all nine type 1 mutants had a point mutation from aspartic acid to asparagine at amino acid 426 and that all four type 2 mutants had a point mutation from lysine to glutamic acid at amino acid 447.


Subject(s)
DNA Topoisomerases, Type II/genetics , Escherichia coli/genetics , Quinolones/pharmacology , Amino Acid Sequence , Binding Sites , Chemical Phenomena , Chemistry, Physical , DNA Topoisomerases, Type II/chemistry , DNA Topoisomerases, Type II/metabolism , DNA, Bacterial/metabolism , Drug Resistance, Microbial/genetics , Escherichia coli/enzymology , Molecular Sequence Data , Mutation/genetics
4.
J Bacteriol ; 172(12): 6942-9, 1990 Dec.
Article in English | MEDLINE | ID: mdl-2174864

ABSTRACT

The norA gene cloned from chromosomal DNA of quinolone-resistant Staphylococcus aureus TK2566 conferred relatively high resistance to hydrophilic quinolones such as norfloxacin, enoxacin, ofloxacin, and ciprofloxacin, but only low or no resistance at all to hydrophobic ones such as nalidixic acid, oxolinic acid, and sparfloxacin in S. aureus and Escherichia coli. The 2.7-kb DNA fragment containing the norA gene had a long open reading frame coding for 388 amino acid residues with a molecular weight of 42,265, which was consistent with the experimental value of about 49,000 obtained on DNA-directed translation. The deduced NorA polypeptide has 12 hydrophobic membrane-spanning regions and is partly homologous to tetracycline resistance protein and sugar transport proteins. The uptake of a hydrophilic quinolone, enoxacin, by S. aureus harboring a plasmid carrying the norA gene was about 50% that by the parent strain lacking the plasmid, but it increased to almost the same level as that by the latter strain with carbonyl cyanide m-chlorophenyl hydrazone. On the other hand, the uptake of a hydrophobic quinolone, sparfloxacin, was similar in the two strains. These results suggest that the NorA polypeptide may constitute a membrane-associated active efflux pump of hydrophilic quinolones.


Subject(s)
Drug Resistance, Microbial , Quinolones/pharmacology , Staphylococcus aureus/genetics , Amino Acid Sequence , Bacterial Proteins/genetics , Base Sequence , Biological Transport , Cloning, Molecular , DNA, Bacterial/genetics , Genes, Bacterial , Molecular Sequence Data , Quinolones/metabolism , Restriction Mapping , Solubility , Staphylococcus aureus/drug effects , Staphylococcus aureus/metabolism
5.
J Biochem ; 108(5): 798-803, 1990 Nov.
Article in English | MEDLINE | ID: mdl-1964456

ABSTRACT

The His-44 and Met-164 residues of yeast cytochrome c1 are evolutionally conserved and regarded as heme axial ligands bonding to the fifth and sixth coordination sites of the heme iron, which is directly involved in the electron transfer mechanism. Oligonucleotide-directed mutagenesis was used to generate mutant forms of cytochrome c1 of yeast having amino acid replacements of the putative axial ligands of the heme iron. When a cytochrome c1-deficiency yeast strain was transformed with a gene encoding the Phe-44, Tyr-44, Leu-164, or Lys-164 protein, none of these transformants could grow on the non-fermentable carbon source. These results suggest that the His-44 and Met-164 residues have a critical role in the function of cytochrome c1 in vivo, most probably as axial ligands of the heme iron. Further analysis revealed that the mutant yeast cells with the Phe-44, Tyr-44, or Leu-164 protein lacked the characteristic difference spectroscopic signal of cytochrome c1. However, in the Lys-164 mutant cells, partial recovery of the cytochrome c1 signal was observed. Moreover, the Lys-164 protein retained a low but significant level of succinate-cytochrome c reductase activity in vitro. The possibility that the nitrogen of Lys-164 served as the sixth heme ligand is discussed in comparison with cytochrome f of a photosynthetic electron-transfer complex, in which lysine has been proposed to be the sixth ligand.


Subject(s)
Cytochromes c1/genetics , Heme/genetics , Iron/chemistry , Saccharomyces cerevisiae/genetics , Base Sequence , Blotting, Western , Electron Transport , Genetic Complementation Test , Ligands , Molecular Sequence Data , Mutagenesis, Site-Directed , Saccharomyces cerevisiae/enzymology , Solubility , Temperature , Transformation, Genetic , X-Ray Diffraction
6.
Antimicrob Agents Chemother ; 34(6): 1271-2, 1990 Jun.
Article in English | MEDLINE | ID: mdl-2168148

ABSTRACT

Nucleotide sequence analysis of the gyrA genes of 10 spontaneous quinolone-resistant gyrA mutants of Escherichia coli KL16, including four mutants examined previously, disclosed that quinolone resistance was caused by a point mutation within the region between amino acids 67 and 106, especially in the vicinity of amino acid 83, of the GyrA protein.


Subject(s)
Anti-Infective Agents/pharmacology , DNA Topoisomerases, Type II/genetics , Escherichia coli/genetics , 4-Quinolones , Drug Resistance, Microbial/genetics , Escherichia coli/drug effects , Mutation
7.
Antimicrob Agents Chemother ; 34(6): 1273-5, 1990 Jun.
Article in English | MEDLINE | ID: mdl-2168149

ABSTRACT

The proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa was examined by introducing the cloned wild-type Escherichia coli gyrA and gyrB genes. Of 101 spontaneous mutants of P. aeruginosa PAO505, 33 (33%) were found to have gyrA mutations. Among 17 clinical isolates, 12 (71%) had gyrA mutations and 1 (6%) had a gyrB mutation.


Subject(s)
Anti-Infective Agents/pharmacology , DNA Topoisomerases, Type II/genetics , Pseudomonas aeruginosa/genetics , 4-Quinolones , Drug Resistance, Microbial/genetics , Mutation , Pseudomonas aeruginosa/drug effects , Transformation, Genetic/physiology
SELECTION OF CITATIONS
SEARCH DETAIL